secwatch / observer
8-K filed June 2, 2026, 6:30 AM ET ticker BJDX CIK 0001704287
other material confidence medium sentiment positive materiality 0.55

Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing

Bluejay Diagnostics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Bluejay Diagnostics, Inc. entered into Agreement and Statement of Work with Argonaut Manufacturing Services with Argonaut Manufacturing Services c/o Argonaut, Inc. valued at Provision of manufacturing services for the Company’s SymphonyTM platform, including planning, engin (effective 2026-05-27).

Action
entry
Counterparty
Argonaut Manufacturing Services c/o Argonaut, Inc.
Value
Provision of manufacturing services for the Company’s SymphonyTM platform, including planning, engin
Effective
2026-05-27
Exact text from the filing
On May 27, 2026, Bluejay Diagnostics, Inc. (the “Company”) entered into an agreement and statement of work (together, the “Agreement”) with Argonaut Manufacturing Services c/o Argonaut, Inc. (“Argonaut”) regarding the provision by Argonaut to the Company of certain manufacturing services to support the Company’s SymphonyTM platform.
View on SEC.gov

Browse all material agreements →

Bluejay Diagnostics, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-26-063767
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.